Correlation Between B3 SA and Olema Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both B3 SA and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining B3 SA and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between B3 SA - and Olema Pharmaceuticals, you can compare the effects of market volatilities on B3 SA and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in B3 SA with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of B3 SA and Olema Pharmaceuticals.

Diversification Opportunities for B3 SA and Olema Pharmaceuticals

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between BOLSY and Olema is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding B3 SA - and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and B3 SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on B3 SA - are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of B3 SA i.e., B3 SA and Olema Pharmaceuticals go up and down completely randomly.

Pair Corralation between B3 SA and Olema Pharmaceuticals

Assuming the 90 days horizon B3 SA - is expected to under-perform the Olema Pharmaceuticals. But the otc pink sheet apears to be less risky and, when comparing its historical volatility, B3 SA - is 1.41 times less risky than Olema Pharmaceuticals. The otc pink sheet trades about -0.3 of its potential returns per unit of risk. The Olema Pharmaceuticals is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest  369.00  in Olema Pharmaceuticals on September 3, 2022 and sell it today you would lose (96.00)  from holding Olema Pharmaceuticals or give up 26.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy90.91%
ValuesDaily Returns

B3 SA -  vs.  Olema Pharmaceuticals

 Performance (%) 
       Timeline  
B3 SA - 
BOLSY Performance
0 of 100
Over the last 90 days B3 SA - has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

BOLSY Price Channel

Olema Pharmaceuticals 
Olema Performance
0 of 100
Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Olema Price Channel

B3 SA and Olema Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with B3 SA and Olema Pharmaceuticals

The main advantage of trading using opposite B3 SA and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if B3 SA position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.
B3 SA vs. SP Global
B3 SA vs. CME Group
B3 SA vs. Intercontinental Exchange
B3 SA vs. Moodys
The idea behind B3 SA - and Olema Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Olema Pharmaceuticals vs. Vertex Pharmaceuticals
Olema Pharmaceuticals vs. Anheuser-Busch InBev SANV
Olema Pharmaceuticals vs. FT Cboe Vest
Olema Pharmaceuticals vs. VANGUARD SMALL-CAP GROWTH
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go